Monkey IFN-γ T cell ELISPOT antibody pair - 10-plate

SKU
CT605-10
Validated ELISPOT antibody pair; reagents available separately (960 determinations).
Species reactivity: rhesus macaque, cynomolgus monkey, pig-tailed macaque, baboon and African green monkey.
Format
10-plate
Price
€ 655
Reactivity
Monkey
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Image

References

Authors, et al. Title Journal Year Volume Pages
Sook Chung Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate Eyes Hum Gene Ther 2021 32 682-693
Yik Wong Sustained viremia suppression by SHIVSF162P3CN-recalled effector-memory CD8+ T cells after PD1-based vaccination PLoS Pathog 2021 17 e1009647
Lisa Frenkel Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge PLoS One 2021 16 e0240495
Yusuke Tsujimura Vaccination with Intradermal Bacillus Calmette-Guérin Provides Robust Protection against Extrapulmonary Tuberculosis but Not Pulmonary Infection in Cynomolgus Macaques J Immunol 2020 205 3023-3036
Satoru Watanabe Protective Immune Responses Elicited by Deglycosylated Live-Attenuated Simian Immunodeficiency Virus Vaccine Are Associated with IL-15 Effector Functions J Immunol 2020 205 1331-1344
Liqiang Feng An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques Nat Commun 2020 11 4207
Federico Napolitano A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C PLoS Negl Trop Dis 2020 14 e0008459
Michel Vierboom Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques NPJ Vaccines 2020 5 39
Karin Dijkman Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques Nat Med 2019 25 255-262
Petra Mooij Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza Vaccine 2019 37 817-826